Extrathoracic PET/CT findings in thoracic malignancies

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Integrated positron emission tomography-computed tomography (PET-CT) is standard for non-small cell lung cancer (NSCLC) staging and follow-up.
• Improved diagnostic accuracy with PET-CT leads to the detection of numerous incidental extrathoracic findings.
• These findings require careful interpretation to distinguish from metastatic disease.

Purpose of the Study:

• To highlight the importance of recognizing incidental extrathoracic findings on PET-CT in NSCLC patients.
• To differentiate benign or unrelated findings from actual metastatic disease.
• To emphasize the role of this knowledge in accurate staging and identifying second primary malignancies.

Main Methods:

• Review of incidental extrathoracic findings encountered during routine PET-CT staging and follow-up of NSCLC patients.
• Categorization of findings into physiologic, normal variants, and potential second primary malignancies.
• Comparison with known patterns of metastatic disease.

Main Results:

• Physiologic fluorodeoxyglucose (FDG) avid foci are common incidental findings.
• Normal computed tomography (CT) variants can mimic metastatic lesions.
• Second primary malignancies are an important consideration among incidental findings.

Conclusions:

• Accurate interpretation of incidental extrathoracic findings on PET-CT is essential for correct NSCLC staging.
• Distinguishing these findings prevents misdiagnosis of metastatic disease.
• Identification of second primary malignancies improves overall patient management and prognosis.